“…However, the scope of these remarkable achievements has been confined to a few model organisms, such as Escherichia coli and Saccharomyces cerevisiae , which have served as the primary platforms for demonstrating novel regulatory modalities and enabling tools. While these organisms have indeed showcased their potential for real‐world applications (e.g., E. coli Nissle 1917‐based bacterial therapeutics against cancer and metabolic disorder [6]), other non‐model organisms, with unique metabolisms (e.g., precursor turnover, product secretion, and tolerance to extreme conditions) and adaptations for specific environments (e.g., human organs, tumors, soil, and ocean), harbor immense potential for a myriad of unexplored applications [7]. Therefore, transferring the genetic parts and tools to non‐model organisms presents a thrilling opportunity to transform genetic circuits from laboratory to field and extend their applications far beyond the traditional boundaries.…”